Bill Information for hr9661-119

Long Title

To amend the Public Health Service Act to codify that the default expectation for licensure of biological products as biosimilar does not include clinical studies assessing pharmacodynamics or comparative clinical efficacy, and for other purposes.

Short Title

Expedited Access to Biosimilars Act

Vote Information

Status: REFERRED as of 2026-07-14 00:00:00.

Sponsor: This bill was sponsored by Nicholas A. Langworthy (R-NY).

Party line votes are determined based on this being a R-sponsored piece of legislation. See here for information on how party line votes are determined.

Vote count: There were 0 roll call votes on this bill in total.